Stem Cell Clinic
Patient Application
FAQ
Contact
Locations
Our Scientific Articles
News
2009
2008
2007
2006
Videos
Research


Stem Cell Company Hosts Training Courses

Reuters, September 1, 2009

The biotech company Stemcell Technologies announced today the schedule for their fall training program. The new curriculum includes a number of 2-day courses, namely, on mesenchymal stem cell biology (October 2nd and 3rd), mammary stem cell biology (October 17th and 18th), neural stem cell biology (October 30th and 31st), hematopoietic stem cell biology (October 30th and 31st), and lastly, human embryonic stem cell and iPS (induced pluripotent stem) cell biology (November 14th and 15th). All courses will be held at the company's Vancouver headquarters and will be taught by scientists who have been personally involved in the actual development of many of the research tools and techniques that are commonly employed in stem cell laboratories around the world today. Hands-on instruction will be emphasized, in conjunction with some lectures.

According to Dr. Chantal Proulx, technical support manager at Stemcell Technologies, "We are dedicated to providing standardized tools and reagents in order to advance research, but this is only half the story. Providing detailed training courses to standardize the techniques that people use to grow their cells is also a key part of the equation."

As described on their website, the biotech company Stemcell Technologies is involved in "the development and marketing of specialty cell culture media, cell separation products and ancillary reagents for life science research." Stemcell Technologies currently delivers more than 900 products to research scientists in over 70 countries worldwide.

Headquartered in Vancouver, British Columbia, Canada, Stemcell Technologies also has corporate offices in France, Germany, the U.K., Australia and Singapore.

Researchers who wish to register for the courses may apply directly with the company.



Copyright © 2004, 2005, 2006, 2007, 2008 Cell Medicine   Disclaimer   Terms and Conditions   8/5/2020